# DAPL1 is activated by Np63 and GRα and regulates lipid metabolism

**Authors:** Heung-Seok Bae, Yong-In Kim, DongWook Kim, Ki-Hoan Nam, KyungSook Han, SunJo Kim, SungWon Kwon, Je-Yoel Cho

PMC · DOI: 10.1007/s00109-025-02636-8 · Journal of Molecular Medicine (Berlin, Germany) · 2026-01-31

## TL;DR

This study shows that DAPL1, a protein activated by Np63 and GRα, plays a role in lipid metabolism and is more active in squamous cell lung cancer than in adenocarcinoma.

## Contribution

The study identifies DAPL1 as a novel regulator of lipid metabolism activated by Np63 and GRα in lung cancer.

## Key findings

- DAPL1 is highly expressed in squamous cell carcinoma but not in adenocarcinoma.
- DAPL1 knockout mice show altered body weight and hair color, indicating its role in lipid metabolism.
- DAPL1 regulates cholesterol, PC, and SM through Fdft1, Pcyt1a, and Sptlc1 gene expression.

## Abstract

Non-small cell lung cancer (NSCLC) accounts for about 80% of all lung cancer occurrences and is divided into largely Adenocarcinoma (LUAD), Squamous cell carcinoma (LUSC), and Large cell carcinoma. In this study, using RNA-seq data between cancer tissues and adjacent normal tissues of 5 LUAD and 4 LUSC patients, we found that a Death associated protein like 1 (DAPL1) was highly expressed in squamous cell carcinoma but not in adenocarcinoma. Through the RNA-seq analysis, we found that lipid metabolic pathway genes Fdft1, Pcyt1a, and Sptlc1 correlate well with DAPL1 level changes in LUSC. We also found that Dapl1 was activated by Np63 and GRα monomer transcription factors. We generated a DAPL1 knockout mouse, which shows body weight and hair color changes, implying the role of DAPL1 in lipid metabolism. Our data show that Np63, GRα transcription factors activate DAPL1, and it is predicted to contribute to cellular acidification by regulating lipid metabolism based on mRNA-seq data and DAPL1 KO mice.

This study uses RNA-seq data between cancer tissues and adjacent normal tissues of 5LUAD and 4LUSC patients.We found that a Death associated protein like 1 (DAPL1) was highly expressed in squamous cell carcinoma but not in adenocarcinoma.We also found that Dapl1 was activated by Np63 and GRα monomer transcription factors.The RNA-seq analysis found that lipid metabolic pathway genes Fdft1, Pcyt1a, and Sptlc1 correlate well with DAPL1 level changes in LUSC.We generated a DAPL1 knockout mice. DAPL1 KO mice were bred at two institutions (KRIBB for phonotypes, and SNU for functions). Interestingly, in KRIBB, DAPL1 KO body weight was lower than WT, and in SNU, DAPL1 KO body weight was higher than WT. In the investigation of mouse chow from the two institutions, differences in choline were noted. When chow with differences only in choline was produced and applied to new DAPL1 KO mice, the same results were obtained.Through RNA-seq data and body weight changes in DAPL1 KO mice, we report that DAPL1 regulates cholesterol, PC, and SM through changes in mRNA of Fdft1, Pcyt1a, and Sptlc1.

This study uses RNA-seq data between cancer tissues and adjacent normal tissues of 5LUAD and 4LUSC patients.

We found that a Death associated protein like 1 (DAPL1) was highly expressed in squamous cell carcinoma but not in adenocarcinoma.

We also found that Dapl1 was activated by Np63 and GRα monomer transcription factors.

The RNA-seq analysis found that lipid metabolic pathway genes Fdft1, Pcyt1a, and Sptlc1 correlate well with DAPL1 level changes in LUSC.

We generated a DAPL1 knockout mice. DAPL1 KO mice were bred at two institutions (KRIBB for phonotypes, and SNU for functions). Interestingly, in KRIBB, DAPL1 KO body weight was lower than WT, and in SNU, DAPL1 KO body weight was higher than WT. In the investigation of mouse chow from the two institutions, differences in choline were noted. When chow with differences only in choline was produced and applied to new DAPL1 KO mice, the same results were obtained.

Through RNA-seq data and body weight changes in DAPL1 KO mice, we report that DAPL1 regulates cholesterol, PC, and SM through changes in mRNA of Fdft1, Pcyt1a, and Sptlc1.

Our data show that Np63, GRα monomer transcription factors activate DAPL1, and it is predicted to regulate lipid metabolism based on mRNA-seq data and DAPL1 KO mice.

The online version contains supplementary material available at 10.1007/s00109-025-02636-8.

## Linked entities

- **Genes:** DAPL1 (death associated protein like 1) [NCBI Gene 92196], FDFT1 (farnesyl-diphosphate farnesyltransferase 1) [NCBI Gene 2222], PCYT1A (phosphate cytidylyltransferase 1A, choline) [NCBI Gene 5130], SPTLC1 (serine palmitoyltransferase long chain base subunit 1) [NCBI Gene 10558], tp63.L (tumor protein p63 L homeolog) [NCBI Gene 373640], gra (gravel) [NCBI Gene 251211]
- **Chemicals:** choline (PubChem CID 305)
- **Diseases:** Non-small cell lung cancer (MONDO:0005233), Adenocarcinoma (MONDO:0004970), Squamous cell carcinoma (MONDO:0005096)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Gpam (glycerol-3-phosphate acyltransferase, mitochondrial) [NCBI Gene 14732] {aka GPAT, GPAT-1, GPAT1, P90}, BLMH (bleomycin hydrolase) [NCBI Gene 642] {aka BH, BMH}, Fdft1 (farnesyl diphosphate farnesyl transferase 1) [NCBI Gene 14137] {aka SQS, SS}, SPTLC1 (serine palmitoyltransferase long chain base subunit 1) [NCBI Gene 10558] {aka ALS27, HSAN1, HSN1, LBC1, LCB1, SPT1}, LSM1 (LSM1 homolog, mRNA degradation associated) [NCBI Gene 27257] {aka CASM, FICUS, YJL124C}, Cdkn1a (cyclin dependent kinase inhibitor 1A) [NCBI Gene 12575] {aka CAP20, CDKI, CIP1, Cdkn1, P21, SDI1}, FNDC3B (fibronectin type III domain containing 3B) [NCBI Gene 64778] {aka FAD104, PRO4979, YVTM2421}, Dapl1 (death associated protein-like 1) [NCBI Gene 76747] {aka 2310032F03Rik, EEDA}, Sptlc1 (serine palmitoyltransferase, long chain base subunit 1) [NCBI Gene 268656] {aka E030036H05, Lcb1, SPT1}, Nr3c1 (nuclear receptor subfamily 3, group C, member 1) [NCBI Gene 14815] {aka GR, Grl-1, Grl1}, GBA1 (glucosylceramidase beta 1) [NCBI Gene 2629] {aka GBA, GCB, GLUC}, ASPRV1 (aspartic peptidase retroviral like 1) [NCBI Gene 151516] {aka ADLI, MUNO, SASP, SASPase, Taps}, Lsm1 (LSM1 homolog, mRNA degradation associated) [NCBI Gene 67207] {aka 2810025O06Rik, CASM}, Pcyt1a (phosphate cytidylyltransferase 1, choline, alpha isoform) [NCBI Gene 13026] {aka CTalpha, Cctalpha, Ctpct, Cttalpha}, SACM1L (SAC1 like phosphatidylinositide phosphatase) [NCBI Gene 22908] {aka SAC1}, DAPL1 (death associated protein like 1) [NCBI Gene 92196], Crh (corticotropin releasing hormone) [NCBI Gene 12918] {aka CRF, Gm1347}, PCYT1A (phosphate cytidylyltransferase 1A, choline) [NCBI Gene 5130] {aka CCTA, CCTalpha, CGL5, CT, CTA, CTPCT}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, Dgat1 (diacylglycerol O-acyltransferase 1) [NCBI Gene 13350] {aka ARAT, D15Ertd23e, Dgat}, NR3C1 (nuclear receptor subfamily 3 group C member 1) [NCBI Gene 2908] {aka GCCR, GCR, GCRST, GR, GRL}, FDFT1 (farnesyl-diphosphate farnesyltransferase 1) [NCBI Gene 2222] {aka DGPT, ERG9, SQS, SQSD, SS}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, TH (tyrosine hydroxylase) [NCBI Gene 7054] {aka DYT14, DYT5b, TYH}, TYR (tyrosinase) [NCBI Gene 7299] {aka ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3}, RAB3IL1 (RAB3A interacting protein like 1) [NCBI Gene 5866] {aka GRAB}, ZIC1 (Zic family zinc finger 1) [NCBI Gene 7545] {aka BAIDCS, CRS6, ZIC, ZNF201}, TSR2 (TSR2 ribosome maturation factor) [NCBI Gene 90121] {aka DBA14, DT1P1A10, WGG1}, Pomc (pro-opiomelanocortin-alpha) [NCBI Gene 18976] {aka ACTH, BE, Beta-LPH, Clip, Gamma-LPH, Npp}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, FHL2 (four and a half LIM domains 2) [NCBI Gene 2274] {aka AAG11, DRAL, FHL-2, SLIM-3, SLIM3}, Pikfyve (phosphoinositide kinase, FYVE type zinc finger containing) [NCBI Gene 18711] {aka 5230400C17Rik, Pip5k, Pip5k3, Pipk5k3, PipkIII, p235}, SLC9A1 (solute carrier family 9 member A1) [NCBI Gene 6548] {aka APNH, LIKNS, NHE-1, NHE1, PPP1R143}
- **Diseases:** tumorigenesis (MESH:D063646), overweight (MESH:D050177), wounds (MESH:D014947), SCLC (MESH:D018288), Hepatoblastoma (MESH:D018197), Parkinson's disease (MESH:D010300), AMD (MESH:D008268), PVR (MESH:D018630), LUAD (MESH:D000077192), NSCLC (MESH:D002289), Large cell carcinoma (MESH:D018287), weight gain (MESH:D015430), Adenocarcinoma (MESH:D000230), LUSC (MESH:D002294), cataracts (MESH:D002386), BHDS (MESH:D058249), renal tumors (MESH:D007680), hypoxia (MESH:D000860), cervix carcinoma (MESH:D002583), Lung cancer (MESH:D008175), embryonal tumor of the liver (MESH:D009373), colon cancer (MESH:D015179), hair loss (MESH:D000505), melanoma (MESH:D008545), chronic infection (MESH:D000088562), small cell lung cancer (MESH:D055752), Cancer (MESH:D009369), WT (MESH:D006969), osteosarcoma (MESH:D012516), drusen (MESH:D015593)
- **Chemicals:** PC (MESH:D010713), carnitines (MESH:D002331), water (MESH:D014867), PA (MESH:D010712), cholesterol esters (MESH:D002788), PC (MESH:C053518), MTBE (MESH:C043243), cortisol (MESH:D006854), Dexamethasone (MESH:D003907), ATP (MESH:D000255), Bet (MESH:D001622), PIP2 (MESH:D019269), amino acids (MESH:D000596), PI (MESH:D010716), PS (MESH:D010758), methanol (MESH:D000432), Free fatty acids (MESH:D005230), TG (MESH:D014280), FA (MESH:D005492), Norepinephrine (MESH:D009638), O2 (MESH:D010100), Acho (MESH:D000109), ammonium formate (MESH:C030544), SM (MESH:D012493), testosterone (MESH:D013739), Choline (MESH:D002794), Cho (MESH:D002784), K+ (MESH:D011188), N2 (MESH:D009584), Corticosterone (MESH:D003345), dopamine (MESH:D004298), GPCho (MESH:D005997), LPC (MESH:D008244), acetonitrile (MESH:C032159), melanin (MESH:D008543), Lipofectamine (MESH:C086724), catecholamine (MESH:D002395), PBS (MESH:D007854), 3uM (-), Ampicillin (MESH:D000667), Lipid (MESH:D008055), 2-propanol (MESH:D019840), toluene (MESH:D014050), TRizol (MESH:C411644), SM (MESH:D013109), CO2 (MESH:D002245), DG (MESH:D004075), Ca (MESH:D002118), epinephrine (MESH:D004837), perfluorooctanoic acid (MESH:C023036), phospholipid (MESH:D010743)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A362A, M180A
- **Cell lines:** CHO MT58 — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_0442), C57BL/6N — Mus musculus (Mouse), Embryonic stem cell (CVCL_2H81), Jurkat T — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065), SKMES1 — Homo sapiens (Human), Lung squamous cell carcinoma, Cancer cell line (CVCL_0630), LUSC — Homo sapiens (Human), Hypopharyngeal squamous cell carcinoma, Cancer cell line (CVCL_0D71), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), RPE — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_IQ82), Caco2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), -T — Homo sapiens (Human), Esophageal squamous cell carcinoma, Cancer cell line (CVCL_3174), SNU — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_D773), HCC95 — Homo sapiens (Human), Lung squamous cell carcinoma, Cancer cell line (CVCL_5137), MG-U74B — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0022)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12860865/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12860865/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12860865/full.md

---
Source: https://tomesphere.com/paper/PMC12860865